CSL Competitors and Similar CompaniesClear all
Walvax Biotechnology's competitors and similar companies include Biohaven Pharmaceutical, Shandong Saito Biotechnology and Serum Institute of India.
 Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. |  Biohaven Pharmaceutical Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system. |  Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. | ||
Founding Date | Founding Date 2001 | Founding Date 2014 | Founding Date 2010 | Founding Date 1966 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Kunming, CN HQ | Locations New Haven, US HQ | Locations Heze, CN HQ | Locations Pune, IN HQ Mumbai, IN Pune, IN |
Employees | Employees 2,388 | Employees 4692% decrease | Employees 1,200 | Employees 4,8671% increase |
Valuation ($) | Valuation ($) 3.4 b | Valuation ($) N/A | Valuation ($) 642.4 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) ¥4.1b (FY, 2023) | Revenue (est.) N/A | Revenue (est.) ¥1.2b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥597.6m (FY, 2023) | Cost of goods N/A | Cost of goods ¥994.2m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit ¥3.5b (FY, 2023) | Gross profit N/A | Gross profit ¥271.8m (FY, 2023) | Gross profit N/A |
Net income | Net income ¥511.3m (FY, 2023) | Net income N/A | Net income ¥48.5m (FY, 2023) | Net income N/A |
Funding | ||||
Total funding raised | Total funding raised $ 72.8m | Total funding raised $ 80m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Biohaven Pharmaceutical
HQ
New Haven, US
Biohaven is engaged in the identification and development of clinical stage neuroscience compounds targeting the glutamatergic system.
View companyShandong Saito Biotechnology
HQ
Heze, CN
Employees
1,200
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View company